Interim analyses at 40% of enrollment are 245 for
Post# of 148112
(Total Views: 731)
Posted On: 03/30/2022 6:56:42 PM
Interim analyses at 40% of enrollment are 245 for moderate and 126 for critical (larger total and subgroups than the totals for CD12).
Four doses in Brazilian trials , four IV for critical.versus 2 doses SQ in CD12.
Interim analysis could easily yield statistical significance along with the known clinical significance.
Let’s go Leron!
Four doses in Brazilian trials , four IV for critical.versus 2 doses SQ in CD12.
Interim analysis could easily yield statistical significance along with the known clinical significance.
Let’s go Leron!
(18)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼